You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 22, June 10, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Living With Uncertainty in the Intensive Care Unit

Should Patients With Sepsis Be Treated With Steroids?

Roman Jaeschke, MD, MSc; Derek C. Angus, MD, MPH

JAMA. 2009;301(22):2388-2390.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Physicians who practiced medicine 25 years ago likely remember the use of high-dose intravenous steroids, such as 1-g boluses of methylprednisolone, for septic shock. The practice was fueled by anecdotes of miraculous recoveries, but large randomized trials failed to demonstrate benefit and raised the specter of possible harm. Steroids were abandoned and lay dormant for years, until recent studies suggested that septic shock may be exacerbated by relative adrenal insufficiency and that smaller dose of steroids for longer periods of time may be beneficial. In 2002, in a multicenter French study, Annane et al1 reported lower mortality among patients in septic shock who were randomized to a 1-week course of low-dose steroids. This study ignited such rapid interest in steroids that the United States temporarily ran out of hydrocortisone. For those who lament the usually slow adoption of evidence into clinical . . . [Full Text of this Article]

Author Affiliations: Department of Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Jaeschke); CRISMA Laboratory, Department of Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Angus). Dr Angus is also Contributing Editor, JAMA.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review
Djillali Annane, Eric Bellissant, Pierre-Edouard Bollaert, Josef Briegel, Marco Confalonieri, Raffaele De Gaudio, Didier Keh, Yizhak Kupfer, Michael Oppert, and G. Umberto Meduri
JAMA. 2009;301(22):2362-2375.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Corticosteroids for Patients with Septic Shock
JWatch General 2009;2009:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.